BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration
- 1 November 2002
- journal article
- case report
- Published by Elsevier BV in Cancer Genetics and Cytogenetics
- Vol. 139 (1), 30-33
- https://doi.org/10.1016/s0165-4608(02)00615-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Marked ploidy and BCR-ABL gene amplification in vivo in a patient treated with STI571Leukemia, 2001
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001
- Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemiaGenes, Chromosomes and Cancer, 2001
- The molecular biology of chronic myeloid leukemiaBlood, 2000
- Amplification of the human dihydrofolate reductase gene via double minutes is initiated by chromosome breaksProceedings of the National Academy of Sciences, 2000
- Cytogenetics of the Chronic Myeloid Leukemia-Derived Cell Line K562Cancer Genetics and Cytogenetics, 2000
- Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplificationBlood, 2000
- Chronic granulocytic leukemia: Correlation of elastic transformation type with karyotypic evolutionAmerican Journal of Hematology, 1985